BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1387 related articles for article (PubMed ID: 15209801)

  • 1. delta-Aminolevulinic acid and blue light photodynamic therapy for treatment of multiple basal cell carcinomas in two patients with nevoid basal cell carcinoma syndrome.
    Itkin A; Gilchrest BA
    Dermatol Surg; 2004 Jul; 30(7):1054-61. PubMed ID: 15209801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Broad area photodynamic therapy for treatment of multiple basal cell carcinomas in a patient with nevoid basal cell carcinoma syndrome.
    Chapas AM; Gilchrest BA
    J Drugs Dermatol; 2006 Feb; 5(2 Suppl):3-5. PubMed ID: 16485873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of diffuse basal cell carcinomas and basaloid follicular hamartomas in nevoid basal cell carcinoma syndrome by wide-area 5-aminolevulinic acid photodynamic therapy.
    Oseroff AR; Shieh S; Frawley NP; Cheney R; Blumenson LE; Pivnick EK; Bellnier DA
    Arch Dermatol; 2005 Jan; 141(1):60-7. PubMed ID: 15655143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photodynamic therapy for large or multiple patches of Bowen disease and basal cell carcinoma.
    Morton CA; Whitehurst C; McColl JH; Moore JV; MacKie RM
    Arch Dermatol; 2001 Mar; 137(3):319-24. PubMed ID: 11255332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Topical photodynamic therapy in basal and squamous cell carcinoma and penile Bowen's disease with 20% aminolevulinic acid, and exposure to red light and infrared light].
    Harth Y; Hirshovitz B
    Harefuah; 1998 Apr; 134(8):602-5, 672, 671. PubMed ID: 10911421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fractionated aminolevulinic acid-photodynamic therapy provides additional evidence for the use of PDT for non-melanoma skin cancer.
    de Haas ER; de Vijlder HC; Sterenborg HJ; Neumann HA; Robinson DJ
    J Eur Acad Dermatol Venereol; 2008 Apr; 22(4):426-30. PubMed ID: 18031503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An open pilot study of ambulatory photodynamic therapy using a wearable low-irradiance organic light-emitting diode light source in the treatment of nonmelanoma skin cancer.
    Attili SK; Lesar A; McNeill A; Camacho-Lopez M; Moseley H; Ibbotson S; Samuel ID; Ferguson J
    Br J Dermatol; 2009 Jul; 161(1):170-3. PubMed ID: 19302071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nodular basal cell carcinoma in Gorlin's syndrome treated with systemic photodynamic therapy and interstitial optical fiber diffuser laser.
    Madan V; Loncaster JA; Allan D; Lear JT; Sheridan L; Leach C; Allan E
    J Am Acad Dermatol; 2006 Nov; 55(5 Suppl):S86-9. PubMed ID: 17052541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo fluorescence kinetics and photodynamic therapy efficacy of delta-aminolevulinic acid-induced porphyrins in basal cell carcinomas and actinic keratoses; implications for optimization of photodynamic therapy.
    Stefanidou M; Tosca A; Themelis G; Vazgiouraki E; Balas C
    Eur J Dermatol; 2000; 10(5):351-6. PubMed ID: 10882942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylaminolaevulinate photodynamic therapy in patients with multiple basal cell carcinomas in the setting of Gorlin-Goltz syndrome or after radiotherapy.
    Mougel F; Debarbieux S; Ronger-Savlé S; Dalle S; Thomas L
    Dermatology; 2009; 219(2):138-42. PubMed ID: 19590166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aminolevulinic acid photodynamic therapy for skin cancers.
    Blume JE; Oseroff AR
    Dermatol Clin; 2007 Jan; 25(1):5-14. PubMed ID: 17126737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of Gorlin syndrome (nevoid basal cell carcinoma syndrome) with methylaminolevulinate photodynamic therapy in seven patients, including two children: interest of tumescent anesthesia for pain control in children.
    Girard C; Debu A; Bessis D; Blatière V; Dereure O; Guillot B
    J Eur Acad Dermatol Venereol; 2013 Feb; 27(2):e171-5. PubMed ID: 22500823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylaminolaevulinate-based photodynamic therapy of Bowen's disease and squamous cell carcinoma.
    Calzavara-Pinton PG; Venturini M; Sala R; Capezzera R; Parrinello G; Specchia C; Zane C
    Br J Dermatol; 2008 Jul; 159(1):137-44. PubMed ID: 18489606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Photodynamic therapy of actinic keratosis at varying fluence rates: assessment of photobleaching, pain and primary clinical outcome.
    Ericson MB; Sandberg C; Stenquist B; Gudmundson F; Karlsson M; Ros AM; Rosén A; Larkö O; Wennberg AM; Rosdahl I
    Br J Dermatol; 2004 Dec; 151(6):1204-12. PubMed ID: 15606516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Photodynamic therapy using aminolaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: phase IV multicentre clinical trial with 12-month follow up.
    Tschen EH; Wong DS; Pariser DM; Dunlap FE; Houlihan A; Ferdon MB;
    Br J Dermatol; 2006 Dec; 155(6):1262-9. PubMed ID: 17107399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photodynamic therapy with 5-aminolaevulinic acid, dimethylsulfoxide and curettage in basal cell carcinoma: a 6-year clinical and histological follow-up.
    Christensen E; Skogvoll E; Viset T; Warloe T; Sundstrøm S
    J Eur Acad Dermatol Venereol; 2009 Jan; 23(1):58-66. PubMed ID: 18803580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of sebaceous gland hyperplasia by photodynamic therapy with 5-aminolevulinic acid and a blue light source or intense pulsed light source.
    Gold MH; Bradshaw VL; Boring MM; Bridges TM; Biron JA; Lewis TL
    J Drugs Dermatol; 2004; 3(6 Suppl):S6-9. PubMed ID: 15624735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Photodynamic therapy of nasal basal cell carcinoma].
    Haddad R; Cohen M; Kaplan O; Greenberg R; Kashtan H
    Harefuah; 2001 Jan; 140(1):25-7, 86. PubMed ID: 11242893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of photodynamic therapy as a treatment for Gorlin syndrome-related basal cell carcinomas.
    Loncaster J; Swindell R; Slevin F; Sheridan L; Allan D; Allan E
    Clin Oncol (R Coll Radiol); 2009 Aug; 21(6):502-8. PubMed ID: 19398312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical investigation of the novel iron-chelating agent, CP94, to enhance topical photodynamic therapy of nodular basal cell carcinoma.
    Campbell SM; Morton CA; Alyahya R; Horton S; Pye A; Curnow A
    Br J Dermatol; 2008 Aug; 159(2):387-93. PubMed ID: 18544077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 70.